[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: 2-Deoxy-D-Glucose (2-DG) powder for oral Solution: 2-deoxy-D-glucose (2-DG) powder for oral solution will be made available for the current study as sachets containing 2.34 g and will be administered as an oral solution at a dose of [approximately] 45 mg/kg of body weight approximately 12 hours apart; in a day)Control Intervention1: Placebo for 2-DG: Placebo for 2-deoxy-D-glucose (2-DG) powder for oral solution will be made available for the current study as sachets containing 2.34 g and will be administered as an oral solution at a dose of [approximately] 45 mg/kg of body weight approximately 12 hours apart; in a day)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: 2-Deoxy-D-Glucose (2-DG) powder for oral Solution: 2-deoxy-D-glucose (2-DG) powder for oral solution will be made available for the current study as sachets containing 2.34 g and will be administered as an oral solution at a dose of [approximately] 45 mg/kg of body weight approximately 12 hours apart; in a day)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Placebo for 2-DG: Placebo for 2-deoxy-D-glucose (2-DG) powder for oral solution will be made available for the current study as sachets containing 2.34 g and will be administered as an oral solution at a dose of [approximately] 45 mg/kg of body weight approximately 12 hours apart; in a day)", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 3, "treatment_name": "2-deoxy-d-glucose", "treatment_type": "Others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: 2-Deoxy-D-Glucose (2-DG) powder for oral Solution: 2-deoxy-D-glucose (2-DG) powder for oral solution will be made available for the current study as sachets containing 2.34 g and will be administered as an oral solution at a dose of [approximately] 45 mg/kg of body weight approximately 12 hours apart; in a day)Control Intervention1: Placebo for 2-DG: Placebo for 2-deoxy-D-glucose (2-DG) powder for oral solution will be made available for the current study as sachets containing 2.34 g and will be administered as an oral solution at a dose of [approximately] 45 mg/kg of body weight approximately 12 hours apart; in a day)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: 2-Deoxy-D-Glucose (2-DG) powder for oral Solution: 2-deoxy-D-glucose (2-DG) powder for oral solution will be made available for the current study as sachets containing 2.34 g and will be administered as an oral solution at a dose of [approximately] 45 mg/kg of body weight approximately 12 hours apart; in a day)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Placebo for 2-DG: Placebo for 2-deoxy-D-glucose (2-DG) powder for oral solution will be made available for the current study as sachets containing 2.34 g and will be administered as an oral solution at a dose of [approximately] 45 mg/kg of body weight approximately 12 hours apart; in a day)", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]